HRP20090679T1 - Upotreba oksikodona za liječenje organske boli - Google Patents
Upotreba oksikodona za liječenje organske boli Download PDFInfo
- Publication number
- HRP20090679T1 HRP20090679T1 HR20090679T HRP20090679T HRP20090679T1 HR P20090679 T1 HRP20090679 T1 HR P20090679T1 HR 20090679 T HR20090679 T HR 20090679T HR P20090679 T HRP20090679 T HR P20090679T HR P20090679 T1 HRP20090679 T1 HR P20090679T1
- Authority
- HR
- Croatia
- Prior art keywords
- pain
- oxycodone
- pharmaceutically acceptable
- acceptable salt
- use according
- Prior art date
Links
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 title claims abstract 22
- 229960002085 oxycodone Drugs 0.000 title claims abstract 22
- 208000009935 visceral pain Diseases 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims abstract 24
- 239000003814 drug Substances 0.000 claims abstract 16
- 208000002193 Pain Diseases 0.000 claims abstract 12
- 238000004519 manufacturing process Methods 0.000 claims abstract 5
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 claims 18
- 229940079593 drug Drugs 0.000 claims 11
- 229960005181 morphine Drugs 0.000 claims 9
- 239000002552 dosage form Substances 0.000 claims 4
- 239000004925 Acrylic resin Substances 0.000 claims 2
- 229920000178 Acrylic resin Polymers 0.000 claims 2
- 208000005171 Dysmenorrhea Diseases 0.000 claims 2
- 208000000112 Myalgia Diseases 0.000 claims 2
- 230000003187 abdominal effect Effects 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- 239000011159 matrix material Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 208000013465 muscle pain Diseases 0.000 claims 2
- 208000004998 Abdominal Pain Diseases 0.000 claims 1
- 206010000087 Abdominal pain upper Diseases 0.000 claims 1
- 206010003011 Appendicitis Diseases 0.000 claims 1
- 206010004663 Biliary colic Diseases 0.000 claims 1
- 208000019399 Colonic disease Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 208000015877 Duodenal disease Diseases 0.000 claims 1
- 206010013935 Dysmenorrhoea Diseases 0.000 claims 1
- 208000037767 Gallbladder pain Diseases 0.000 claims 1
- 206010019705 Hepatic pain Diseases 0.000 claims 1
- 208000007914 Labor Pain Diseases 0.000 claims 1
- 208000035945 Labour pain Diseases 0.000 claims 1
- 206010033645 Pancreatitis Diseases 0.000 claims 1
- 206010035623 Pleuritic pain Diseases 0.000 claims 1
- 208000004550 Postoperative Pain Diseases 0.000 claims 1
- 206010038490 Renal pain Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 238000013270 controlled release Methods 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 230000002183 duodenal effect Effects 0.000 claims 1
- 208000018595 duodenum disease Diseases 0.000 claims 1
- 201000006549 dyspepsia Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000013265 extended release Methods 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 1
- 239000008024 pharmaceutical diluent Substances 0.000 claims 1
- 210000000813 small intestine Anatomy 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64549005P | 2005-01-18 | 2005-01-18 | |
| PCT/EP2006/050252 WO2006077212A1 (en) | 2005-01-18 | 2006-01-17 | Use of oxycodone for treating visceral pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20090679T1 true HRP20090679T1 (hr) | 2010-01-31 |
Family
ID=35871217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20090679T HRP20090679T1 (hr) | 2005-01-18 | 2009-12-18 | Upotreba oksikodona za liječenje organske boli |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US20080200493A1 (he) |
| EP (1) | EP1838318B1 (he) |
| JP (1) | JP5049139B2 (he) |
| KR (10) | KR20220165797A (he) |
| CN (1) | CN101106996B (he) |
| AP (1) | AP2249A (he) |
| AR (1) | AR052880A1 (he) |
| AT (2) | ATE446092T1 (he) |
| AU (1) | AU2006207498B2 (he) |
| BR (1) | BRPI0606247A2 (he) |
| CA (1) | CA2595043C (he) |
| CY (1) | CY1109660T1 (he) |
| DE (2) | DE202006019887U1 (he) |
| DK (2) | DK1838318T3 (he) |
| EA (1) | EA013544B1 (he) |
| ES (1) | ES2333901T3 (he) |
| HK (1) | HK1107933A1 (he) |
| HR (1) | HRP20090679T1 (he) |
| IL (1) | IL184530A (he) |
| ME (1) | ME01066B (he) |
| MX (1) | MX2007007207A (he) |
| MY (1) | MY144471A (he) |
| NO (1) | NO338968B1 (he) |
| NZ (1) | NZ555852A (he) |
| PL (1) | PL1838318T3 (he) |
| PT (1) | PT1838318E (he) |
| RS (1) | RS51069B (he) |
| SI (1) | SI1838318T1 (he) |
| TW (1) | TWI432196B (he) |
| UA (1) | UA85471C2 (he) |
| WO (1) | WO2006077212A1 (he) |
| ZA (1) | ZA200705231B (he) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2380592T1 (en) | 2005-11-14 | 2018-06-29 | Teva Pharmaceuticals International Gmbh | The antibody to the calcitonin-related peptide antagonist |
| CA2687192C (en) | 2007-06-04 | 2015-11-24 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
| CN101959528A (zh) | 2008-03-04 | 2011-01-26 | 辉瑞有限公司 | 治疗慢性疼痛的方法 |
| CA2751667C (en) | 2009-02-06 | 2016-12-13 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
| NZ597283A (en) | 2009-06-24 | 2013-07-26 | Egalet Ltd | Controlled release formulations |
| EP3165236B1 (en) * | 2009-08-28 | 2022-03-16 | Teva Pharmaceuticals International GmbH | Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide |
| BR112013029959A8 (pt) | 2011-05-20 | 2021-09-08 | Alderbio Holdings Llc | Anticorpos anti-cgrp e anti-cgrpr e seu uso para prevenir ou inibir fotofobia ou aversão à luz, composição farmacêutica compreendendo os referidos anticorpos, bem como sequência de ácido nucleico e célula recombinante |
| AU2012258976B8 (en) | 2011-05-20 | 2017-07-20 | H. Lundbeck A/S | Use of anti-CGRP or anti-CGRP-R antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea |
| HUE044062T2 (hu) | 2011-05-20 | 2019-09-30 | Alderbio Holdings Llc | Anti-CGRP készítmények és alkalmazásuk |
| US10556945B2 (en) | 2014-03-21 | 2020-02-11 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| PE20220337A1 (es) | 2014-03-21 | 2022-03-14 | Teva Pharmaceuticals Int Gmbh | Anticuerpos antagonistas dirigidos contra el peptido relacionado con el gen de calcitonina y metodos que usan los mismos |
| KR20220031944A (ko) | 2016-09-23 | 2022-03-14 | 테바 파마슈티컬스 인터내셔널 게엠베하 | 불응성 편두통의 치료 |
| CA3115122A1 (en) | 2018-11-19 | 2020-05-28 | Jazz Pharmaceuticals Ireland Limited | Alcohol-resistant drug formulations |
| SG11202106766SA (en) | 2019-01-08 | 2021-07-29 | H Lundbeck As | Acute treatment and rapid treatment of headache using anti-cgrp antibodies |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5656295A (en) * | 1991-11-27 | 1997-08-12 | Euro-Celtique, S.A. | Controlled release oxycodone compositions |
| US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
| US5958459A (en) * | 1991-12-24 | 1999-09-28 | Purdue Pharma L.P. | Opioid formulations having extended controlled released |
| US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| IL110014A (en) * | 1993-07-01 | 1999-11-30 | Euro Celtique Sa | Solid controlled-release oral dosage forms of opioid analgesics |
| US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
| BR9708254A (pt) * | 1996-03-25 | 1999-08-03 | Lilly Co Eli | Método para o tratamento da dor |
| UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
| US6992193B2 (en) * | 2003-06-10 | 2006-01-31 | Adolor Corporation | Sulfonylamino phenylacetamide derivatives and methods of their use |
-
2006
- 2006-01-05 TW TW095100458A patent/TWI432196B/zh not_active IP Right Cessation
- 2006-01-09 MY MYPI20060082A patent/MY144471A/en unknown
- 2006-01-17 CA CA2595043A patent/CA2595043C/en active Active
- 2006-01-17 KR KR1020227041445A patent/KR20220165797A/ko not_active Application Discontinuation
- 2006-01-17 KR KR1020197035201A patent/KR20190135557A/ko not_active Application Discontinuation
- 2006-01-17 PL PL06700652T patent/PL1838318T3/pl unknown
- 2006-01-17 ME MEP-2009-352A patent/ME01066B/me unknown
- 2006-01-17 DE DE202006019887U patent/DE202006019887U1/de not_active Expired - Lifetime
- 2006-01-17 AT AT06700652T patent/ATE446092T1/de active
- 2006-01-17 EP EP06700652A patent/EP1838318B1/en active Active
- 2006-01-17 AU AU2006207498A patent/AU2006207498B2/en active Active
- 2006-01-17 PT PT06700652T patent/PT1838318E/pt unknown
- 2006-01-17 WO PCT/EP2006/050252 patent/WO2006077212A1/en active Application Filing
- 2006-01-17 KR KR1020087029312A patent/KR20080106991A/ko active Application Filing
- 2006-01-17 US US11/814,020 patent/US20080200493A1/en not_active Abandoned
- 2006-01-17 EA EA200701541A patent/EA013544B1/ru not_active IP Right Cessation
- 2006-01-17 KR KR1020147018838A patent/KR20140091782A/ko not_active Application Discontinuation
- 2006-01-17 MX MX2007007207A patent/MX2007007207A/es active IP Right Grant
- 2006-01-17 RS RSP-2009/0553A patent/RS51069B/sr unknown
- 2006-01-17 KR KR1020237042001A patent/KR20230170811A/ko active Application Filing
- 2006-01-17 UA UAA200708142A patent/UA85471C2/ru unknown
- 2006-01-17 DE DE602006009899T patent/DE602006009899D1/de active Active
- 2006-01-17 AP AP2007004057A patent/AP2249A/xx active
- 2006-01-17 JP JP2007550797A patent/JP5049139B2/ja not_active Expired - Fee Related
- 2006-01-17 KR KR1020207031796A patent/KR20200128451A/ko not_active Application Discontinuation
- 2006-01-17 CN CN2006800024739A patent/CN101106996B/zh active Active
- 2006-01-17 KR KR1020177004572A patent/KR20170021905A/ko not_active Application Discontinuation
- 2006-01-17 NZ NZ555852A patent/NZ555852A/en unknown
- 2006-01-17 ES ES06700652T patent/ES2333901T3/es active Active
- 2006-01-17 KR KR1020077018905A patent/KR20070100368A/ko not_active Application Discontinuation
- 2006-01-17 KR KR1020127011713A patent/KR20120089710A/ko not_active Application Discontinuation
- 2006-01-17 BR BRPI0606247-4A patent/BRPI0606247A2/pt not_active Application Discontinuation
- 2006-01-17 KR KR1020217034339A patent/KR20210131450A/ko not_active Application Discontinuation
- 2006-01-17 SI SI200630538T patent/SI1838318T1/sl unknown
- 2006-01-17 DK DK06700652T patent/DK1838318T3/da active
- 2006-01-18 AR ARP060100177A patent/AR052880A1/es unknown
-
2007
- 2007-03-09 AT AT0014807U patent/AT9895U1/de not_active IP Right Cessation
- 2007-07-02 ZA ZA200705231A patent/ZA200705231B/xx unknown
- 2007-07-10 IL IL184530A patent/IL184530A/he active IP Right Grant
- 2007-07-24 DK DK200700207U patent/DK200700207U3/da not_active IP Right Cessation
- 2007-08-14 NO NO20074174A patent/NO338968B1/no not_active IP Right Cessation
- 2007-12-12 HK HK07113550.8A patent/HK1107933A1/xx unknown
-
2009
- 2009-12-16 CY CY20091101308T patent/CY1109660T1/el unknown
- 2009-12-18 HR HR20090679T patent/HRP20090679T1/hr unknown
-
2014
- 2014-10-15 US US14/515,216 patent/US9271974B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20090679T1 (hr) | Upotreba oksikodona za liječenje organske boli | |
| RU2404750C2 (ru) | Композиция, содержащая основу или покрытие для замедленного высвобождения и антагонист nmda рецептора, способ введения такого nmda антагониста субъекту | |
| JP2008526927A5 (he) | ||
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| DK2574167T3 (en) | LIQUID NOSE SPRAY CONTAINING low-dose naltrexone | |
| RU2007132181A (ru) | ПРОТИВОРАКОВОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ α,α,α-ТРИФТОРТИМИДИН И ИНГИБИТОР ТИМИДИНФОСФОРИЛАЗЫ | |
| RU2011110765A (ru) | Фармацевтическая композиция энтакапона или его солей пролонгрированного высвобождения | |
| CA3037089C (en) | Sublingual pharmaceutical composition of edaravone and (+)-2-borneol | |
| CN102204904B (zh) | 左旋奥拉西坦在制备预防或治疗认知功能障碍药物中的应用 | |
| JPH0222229A (ja) | 神経細胞及び神経繊維の疾患もしくは傷害の治療に用いる組み合わせ調合剤 | |
| JP2019517542A5 (he) | ||
| HRP20230272T1 (hr) | Postupci za liječenje cistične fibroze | |
| JP2007302657A (ja) | 痙症の兆候および症候の緩和方法 | |
| RU2008102911A (ru) | Фармацевтические составы на основе гуанфацина, подходящие для ежедневного введения в виде единичной дозированной формы | |
| JP2018507243A5 (he) | ||
| HUE029677T2 (hu) | Készítmények centrálisan mediált émelygés és hányás kezelésére | |
| RU2006139819A (ru) | Применение симетикона для предрасположенных к запорам пациентов | |
| BR112013010829B1 (pt) | Omposição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação | |
| JP2001510795A5 (he) | ||
| AU2018357350B2 (en) | Delayed release deferiprone tablets and methods of using the same | |
| WO2007120485A2 (en) | Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor | |
| RU2007101695A (ru) | Лекарственный препарат для лечения сахарного диабета на основе экзенатида и даларгина, применение и способ лечения | |
| RU2261098C2 (ru) | Перорально распадающаяся композиция, содержащая миртазапин | |
| JPWO2021202419A5 (he) | ||
| ES2668943T3 (es) | Composición farmacéutica para tratar eyaculación precoz y método de tratamiento de la eyaculación precoz |